Some of the early published accounts of thyroid hormone (TH) augmentation for mood disorders date back to the 1950s with the discovery of the antidepressant activity of thyroid hormones, leading to the use of liothyronine (T3) augmentation for refractory depression [5,6,7]. This evidence concerns the gene TG and mood disorder.